Nahid A. Qushmaq: MicroRNAs as Prognostic Biomarkers in Septic Patients
Nahid A. Qushmaq, General Supervisor Assistant for Medical Support Services, Consultant Adult Hematology of Thrombosis and Hemostasis, Head Of Research and Development Department at King Abdullah Medical Complex – Jeddah, shared May AlMoshary’s post on LinkedIn:
”Happy and proud to share our new publication with my esteemed colleagues:
‘Prognostic Value of MicroRNA Profile in Septic Patients with Rare Hereditary Anemias: Insights from a Longitudinal Cohort Study.’
Grateful for the collaboration and dedication behind this work.”
May AlMoshary, Cheif medical executive at Private company, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in International Journal of General Medicine, adding:
”I’m happy to share that our paper is now available online in the International Journal of General Medicine.
This study explores the potential role of miR-155 as a diagnostic and prognostic biomarker in patients with rare hereditary anemias presenting with sepsis, with promising findings for its future use in personalized and miRNA-based therapeutic approaches.
Grateful to all co-authors and colleagues who contributed to this work.”
Title: Prognostic Value of MicroRNA Profiles in Septic Patients with Rare Hereditary Anemias: Insights from a Longitudinal Cohort Study
Authors: May AlMoshary, Nahid Abdulhamid Qushmaq, Abba Elgujja, Abdullah Mikki Alamoudi, Maha Abuhatlah AlQahtani, Hind Bugshan, Marytonia Valiyaveettil Antony, Fatimah Alshahrani
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question